• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞士获得性急性肝炎的病因:戊型肝炎病毒。

Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland.

机构信息

Division of Gastroenterology and Hepatology, University Hospital Lausanne, Lausanne, Switzerland.

Institute of Microbiology, University Hospital Lausanne, Lausanne, Switzerland.

出版信息

Liver Int. 2018 Apr;38(4):619-626. doi: 10.1111/liv.13557. Epub 2017 Sep 7.

DOI:10.1111/liv.13557
PMID:28834649
Abstract

BACKGROUND

Autochthonous hepatitis E is increasingly recognized as zoonotic infection in western countries. Serological assays have varying sensitivity and specificity.

METHODS

We implemented molecular testing to identify and characterize acute hepatitis E acquired in Switzerland.

RESULTS

Ninety-three cases of mostly symptomatic acute hepatitis E acquired in Switzerland were documented by PCR between November 2011 and December 2016. Median HEV RNA was 7.5 x 10 IU/mL (range, 5.3 to 4.7 x 10 IU/mL). HEV genotyping was successful in 78 patients, revealing genotype 3 in 75 and genotype 4 in three patients. Phylogenetic analyses revealed a few limited geographical and temporal clusters. Of the 91 patients with available anti-HEV IgM serology, four were negative; three of these were also IgG-negative, likely as a result of immunosuppression, and one was IgG-positive, a constellation compatible with HEV reinfection. Median age of the patients was 58 years (range, 20-80 years); 71 (76.3%) were men and 49 of these (69.0%) were ≥ 50 years old. The clinical course was particularly severe in patients with underlying chronic liver disease, with fatal outcome in two patients. Six patients (6.5%) presented with neuralgic amyotrophy.

CONCLUSIONS

Nucleic acid-based diagnosis reveals HEV as a relevant cause of acute hepatitis in Switzerland. Middle-aged and elderly men constitute the majority of symptomatic patients. Testing for HEV should be included early in the diagnostic workup of acute hepatitis and of neuralgic amyotrophy, a typical extrahepatic manifestation of HEV genotype 3 infection.

摘要

背景

在西方国家,自生型戊型肝炎越来越被认为是一种人畜共患感染。血清学检测方法的敏感性和特异性存在差异。

方法

我们实施了分子检测,以鉴定和描述在瑞士获得的急性戊型肝炎。

结果

2011 年 11 月至 2016 年 12 月期间,通过 PCR 共记录了 93 例在瑞士获得的主要表现为症状性急性戊型肝炎病例。中位 HEV RNA 为 7.5×10 IU/mL(范围为 5.3 至 4.7×10 IU/mL)。78 例患者的 HEV 基因分型成功,其中 75 例为基因型 3,3 例为基因型 4。系统进化分析显示存在少数有限的地理和时间聚类。在 91 例具有可用抗-HEV IgM 血清学的患者中,有 4 例为阴性;其中 3 例也是 IgG 阴性,可能是由于免疫抑制所致,1 例是 IgG 阳性,这一组合与 HEV 再感染相符。患者的中位年龄为 58 岁(范围为 20-80 岁);71 例(76.3%)为男性,其中 49 例(69.0%)≥50 岁。患有基础慢性肝病的患者的临床病程特别严重,有 2 例患者死亡。6 例(6.5%)患者出现神经痛性肌萎缩。

结论

基于核酸的诊断显示 HEV 是瑞士急性肝炎的一个重要原因。中年和老年男性构成了大多数有症状患者的主体。在急性肝炎和神经痛性肌萎缩的诊断中,应尽早进行 HEV 检测,神经痛性肌萎缩是 HEV 基因型 3 感染的一种典型肝外表现。

相似文献

1
Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland.瑞士获得性急性肝炎的病因:戊型肝炎病毒。
Liver Int. 2018 Apr;38(4):619-626. doi: 10.1111/liv.13557. Epub 2017 Sep 7.
2
Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018-2020.2018-2020 年瑞士献血者中急性戊型肝炎病毒感染的流行情况。
Viruses. 2024 May 8;16(5):744. doi: 10.3390/v16050744.
3
Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy.戊型肝炎病毒相关的神经性肌萎缩的临床表型与预后
Neurology. 2017 Aug 29;89(9):909-917. doi: 10.1212/WNL.0000000000004297. Epub 2017 Aug 2.
4
Detection of hepatitis E virus RNA and genotype in Bangladesh.孟加拉国戊型肝炎病毒RNA及基因型的检测
J Gastroenterol Hepatol. 2009 Apr;24(4):599-604. doi: 10.1111/j.1440-1746.2008.05677.x. Epub 2008 Dec 1.
5
Four-year long (2014-2017) clinical and laboratory surveillance of hepatitis E virus infections using combined antibody, molecular, antigen and avidity detection methods: Increasing incidence and chronic HEV case in Hungary.采用联合抗体、分子、抗原和亲和性检测方法对戊型肝炎病毒感染进行的四年(2014-2017 年)临床和实验室监测:匈牙利戊型肝炎病毒感染发病率和慢性戊型肝炎病毒病例不断增加。
J Clin Virol. 2020 Mar;124:104284. doi: 10.1016/j.jcv.2020.104284. Epub 2020 Jan 27.
6
Clinical and virological profiling of sporadic hepatitis E virus infection in China.中国散发性戊型肝炎病毒感染的临床和病毒学特征分析。
J Infect. 2016 Sep;73(3):271-9. doi: 10.1016/j.jinf.2016.06.005. Epub 2016 Jun 22.
7
Detailed investigation of ongoing subclinical hepatitis E virus infections; occurring in outbreak settings of North India.详细调查正在发生的亚临床戊型肝炎病毒感染;发生在印度北部的暴发环境中。
Liver Int. 2015 Mar;35(3):826-33. doi: 10.1111/liv.12568. Epub 2014 May 20.
8
High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.2014 年 2 月至 3 月,意大利中部献血者中抗戊型肝炎病毒抗体的高流行率。
Euro Surveill. 2016 Jul 28;21(30). doi: 10.2807/1560-7917.ES.2016.21.30.30299.
9
Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium.在比利时弗兰德斯的一家三级护理中心,戊型肝炎病毒感染的临床负担。
J Clin Virol. 2018 Jun;103:8-11. doi: 10.1016/j.jcv.2018.03.004. Epub 2018 Mar 19.
10
Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response.戊型肝炎病毒3型感染的血清学反应:IgG定量、亲和力及IgM反应。
J Med Virol. 2008 Jan;80(1):95-101. doi: 10.1002/jmv.21033.

引用本文的文献

1
Unraveling the mysteries of parsonage turner syndrome: A journey towards optimal management. A systematic review.揭开帕森奇-特纳综合征之谜:迈向最佳管理的征程。一项系统综述。
J Hand Microsurg. 2024 Aug 9;16(5):100142. doi: 10.1016/j.jham.2024.100142. eCollection 2024 Dec.
2
Hepatitis E as a trigger for acute-on-chronic liver failure.戊型肝炎作为慢性肝病急性肝衰竭的诱因。
Clin Mol Hepatol. 2025 Feb;31(Suppl):S196-S204. doi: 10.3350/cmh.2024.0758. Epub 2024 Nov 11.
3
HEV ORF2 protein-antibody complex deposits are associated with glomerulonephritis in hepatitis E with reduced immune status.
戊型肝炎病毒 ORF2 蛋白-抗体复合物沉积与免疫功能低下的戊型肝炎相关肾小球肾炎有关。
Nat Commun. 2024 Oct 14;15(1):8849. doi: 10.1038/s41467-024-53072-0.
4
Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018-2020.2018-2020 年瑞士献血者中急性戊型肝炎病毒感染的流行情况。
Viruses. 2024 May 8;16(5):744. doi: 10.3390/v16050744.
5
Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant.异基因造血细胞移植受者中的戊型肝炎病毒感染流行病学
Open Forum Infect Dis. 2023 Nov 24;10(12):ofad595. doi: 10.1093/ofid/ofad595. eCollection 2023 Dec.
6
Epidemiology of HEV Infection in Blood Donors in Southern Switzerland.瑞士南部献血者中戊型肝炎病毒感染的流行病学
Microorganisms. 2023 Sep 22;11(10):2375. doi: 10.3390/microorganisms11102375.
7
Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study.与戊型肝炎病毒感染相关的神经病变:一项前瞻性、配对病例对照研究。
Eur J Neurol. 2024 Jan;31(1):e16030. doi: 10.1111/ene.16030. Epub 2023 Aug 25.
8
Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus.青蒿琥酯的再利用,一种抗疟药物,作为戊型肝炎病毒的潜在抑制剂。
Arch Virol. 2023 Apr 28;168(5):147. doi: 10.1007/s00705-023-05770-1.
9
Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood-brain barrier, and invades the central nervous system.戊型肝炎病毒感染脑微血管内皮细胞,穿过血脑屏障,侵犯中枢神经系统。
Proc Natl Acad Sci U S A. 2022 Jun 14;119(24):e2201862119. doi: 10.1073/pnas.2201862119. Epub 2022 Jun 7.
10
[Vaccines against hepatitis E virus: state of development].[戊型肝炎病毒疫苗:研发进展]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Feb;65(2):192-201. doi: 10.1007/s00103-022-03487-1. Epub 2022 Jan 31.